Locoregional Therapy Pressure-Enabled Drug Delivery for Liver Cancers
Cancers · 23.07.2026 · 18 (15) · 2367
DOI: 10.3390/cancers18152367 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.07.2026. Verfasst von Thomas Eggleston und 3 weiteren Autor:innen. Beteiligte Einrichtung: Corewell Health Lakeland Hospitals-St. Joseph's Hospital, St. Joseph, MI 49085, USA. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatic malignancies account for a substantial portion of global cancer mortality, with hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (IHC), and metastatic liver disease representing the most common diagnoses. While surgical resection and liver transplantation remain curative options for eligible patients, most patients are diagnosed at stages unsuitable for surgery. This has shifted medical management towards locoregional therapies (LRTs) which are often catheter-directed. Of these interventions, the use of conventional end-hole catheters for therapeutic infusion has been a mainstay of treatment, but this method is constrained by retrograde particle escape and elevated tumoral interstitial fluid pressure. Together, these factors limit drug penetration into the tumor microenvironment. Pressure-enabled drug delivery (PEDD), achieved through balloon-occlusion or microvalve-based catheter platforms, has emerged as a strategy to overcome these limitations. This narrative review synthesizes current evidence regarding PEDD and contextualizes its role within the broader LRT landscape. Preclinical studies and early clinical data illustrate improved drug-delivery characteristics, acceptable safety profiles, and highlight the potential for adaptation to regional immunotherapy regimens. However, while PEDD represents a promising advance in catheter-based hepatic oncologic therapy, prospective randomized comparisons against conventional infusion remain limited, and significant investigation is needed to establish its definitive role in interventional oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Corewell Health Lakeland Hospitals-St. Joseph's Hospital, St. Joseph, MI 49085, USA.
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
- The Kentucky College of Osteopathic Medicine, Pikeville, KY 41501, USA.
- Division of Vascular and Interventional Radiology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
ORCID-Profile: Fady Bassem Fayek, Mina S Makary
Zitieren
APA
Eggleston, T., Fayek, F. B., Kowalke, J., & Makary, M. S. (2026). Locoregional Therapy Pressure-Enabled Drug Delivery for Liver Cancers. Cancers, 18(15), 2367. https://doi.org/10.3390/cancers18152367
Vancouver
Eggleston T, Fayek FB, Kowalke J, Makary MS. Locoregional Therapy Pressure-Enabled Drug Delivery for Liver Cancers. Cancers. 2026;18(15):2367. doi:10.3390/cancers18152367
BibTeX
@article{Eggleston2026,
author = {Eggleston, Thomas and Fayek, Fady Bassem and Kowalke, Jacqueline and Makary, Mina S},
title = {Locoregional Therapy Pressure-Enabled Drug Delivery for Liver Cancers},
journal = {Cancers},
year = {2026},
volume = {18},
number = {15},
pages = {2367},
doi = {10.3390/cancers18152367}
}
EUVIMED